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 Chapter 4. Systematic Review of EED 
Biomarkers/Diagnostic Tests: Results 
Synopsis 
4.1 Biomarkers and Diagnostics Systematic Search 
Results 
The query of our EED Library to identify references potentially relevant to the systematic 
review produced 361 citations for the time period between 2000 and 2010. The "snowball" 
technique identified 13 additional potentially relevant publications that were not found through 
the original systematic search. Thirty-three of the 374 potentially relevant publications were in 
languages other than those that we included for this review—English, French, German, Italian, 
Portuguese, and Spanish (Table 8).  
Table 8. Breakdown of publications in excluded languages of potential relevance to the 
systematic review. 
Language Number potentially relevant 
Number sufficiently reviewed 
and excluded for reasons other 
than language 
Arabic 1 0 
Chinese 3 1 
Croatian 2 2 
Czech 2 1 
Norwegian 1 0 
Polish 14 10 
Russian 9 6 
Turkish 1 1 
Totals 33 21 
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 However, we were able to determine (via translation and/or English language abstract) 
that 21 of the 33 did not meet our other systematic review inclusion criteria. We were unable to 
sufficiently translate the remaining 12 papers to determine their relevance or, if they were 
relevant, to extract data. These papers were in Arabic (n=1), Chinese (n=2), Czech (n=1), 
Norwegian (n=1), Polish (n=4), and Russian (n=3). Two-hundred and fifty publications were 
eliminated for various reasons, including their focus on celiac disease, cow’s milk protein 
allergy, or inflammatory bowel disease; lack of at least three subjects of interest under five years 
of age; or they did not assess biomarkers or diagnostic tests related to small intestinal function 
or inflammation. One potentially relevant article was thought to be pertinent to the systematic 
review based on the abstract, and another article required full text for further determination; 
however, the full texts for these two articles could not be found. 
An additional 12 references were highly considered for inclusion, but ultimately excluded 
from the review for reasons including insufficient subjects in the specified age range, inadequate 
relevant data on appropriately-aged subjects, or uncertainty about the setting in which the study 
was performed (Appendix 5).  
We identified 20 review articles with content that addressed or discussed material of 
relevance to our systematic review question (Appendix 6); however, we identified no systematic 
review that had been conducted on biomarkers or diagnostic tests related to EED.  
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 4.2 Characteristics of References Included in the 
Systematic Review 
The remaining 77 references included in the systematic review (Table 9) describe 
research that was performed in 22 different countries. Figure 7 maps the sites where the studies 
were performed.  
Table 9. Articles pertinent to the systematic review. 
These were determined to be the publications of interest between 2000 and 2010. 
Alcantara CS, et al. Interleukin-8, tumor necrosis factor-alpha, and lactoferrin in immunocompetent hosts with 
experimental and Brazilian children with acquired cryptosporidiosis. 2003. [101] 
Alves GM, et al. Nutritional status and breath hydrogen test with lactose and lactulose in Terena Indian 
children. 2002. [102] 
Amadi B, et al. Reduced production of sulfated glycosaminoglycans occurs in Zambian children with 
kwashiorkor but not marasmus. 2009. [103] 
Azim T, et al. Immune response of Bangladeshi children with AD who subsequently have persistent diarrhea. 
2000. [104] 
Bhatnagar S, et al. Celiac disease with mild to moderate histological changes is a common cause of chronic 
diarrhea in Indian children. 2005. [105] 
Bitarakwate E, et al. Serum zinc status of children with persistent diarrhoea admitted to the diarrhoea 
management unit of Mulago Hospital, Uganda. 2003. [106] 
Bukhari AS, et al. DNA damage and plasma homocysteine levels are associated with serum metabolites and 
mineral constituents' profiles in children with persistent diarrhea. 2010. [107] 
Bushen OY, et al. Heavy cryptosporidial infections in children in northeast Brazil: comparison of 
Cryptosporidium hominis and Cryptosporidium parvum. 2007. [108] 
Bustos M, et al. Disaccharidase deficiency in Bolivian children with persistent diarrhea. 2003. [109] 
Campbell DI, et al. Intestinal inflammation measured by fecal neopterin in Gambian children with enteropathy: 
association with growth failure, Giardia lamblia, and intestinal permeability. 2004. [15] 
Campbell DI, et al. Growth faltering in rural Gambian infants is associated with impaired small intestinal barrier 
function, leading to endotoxemia and systemic inflammation. 2003. [110] 
Campbell DI, et al. Chronic T cell-mediated enteropathy in rural west African children: relationship with 
nutritional status and small bowel function. 2003. [111] 
Campbell DI, et al. Age-related association of small intestinal mucosal enteropathy with nutritional status in 
rural Gambian children. 2002. [112] 
Chen P, et al. Association of vitamin A and zinc status with altered intestinal permeability: analyses of cohort 
data from northeastern Brazil. 2003. [113] 
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 Clark TD, et al. Risk factors and cumulative incidence of anaemia among human immunodeficiency virus-
infected children in Uganda. 2002. [114] 
Darboe MK, et al. Effectiveness of an early supplementation scheme of high-dose vitamin A versus standard 
WHO protocol in Gambian mothers and infants: a randomised controlled trial. 2007. [115] 
Dini E, et al. Sudan III and steatocrit in the detection of fecal fat in malnourished children. 2002. [116] 
El Mouzan MI, et al. Endoscopic duodenal biopsy in children. 2006. [117] 
Fagundes-Neto U, et al. Studies of the small bowel surface by scanning electron microscopy in infants with 
persistent diarrhea. 2000. [118] 
Filteau SM, et al. The effect of antenatal vitamin A and (beta)-carotene supplementation on gut integrity of 
infants of HIV-infected South African women. 2001. [119] 
Galpin L, et al. Effect of Lactobacillus GG on intestinal integrity in Malawian children at risk of tropical 
enteropathy. 2005. [120] 
Gandolfi L, et al. Antiendomysial antibody test reliability in children with frequent diarrhea and malnutrition: is it 
celiac disease? 2001. [121] 
Goto R, et al. Impact of anti-Giardia and anthelminthic treatment on infant growth and intestinal permeability in 
rural Bangladesh: a randomised double-blind controlled study. 2008. [122] 
Goto R, et al. Impact of intestinal permeability, inflammation status and parasitic infections on infant growth 
faltering in rural Bangladesh. 2008. [123] 
Goto R, et al. Poor intestinal permeability in mildly stunted Nepali children: Associations with weaning practices 
and Giardia lamblia infection. 2002. [124] 
Haase A, et al. Dual sugar permeability testing in diarrheal disease. 2000. [125] 
Hafeez A, et al. An audit of pediatric upper gastrointestinal endoscopies. 2000. [126] 
Jain S, et al. Fecal occult blood screening in children with severe malnutrition. 2007. [127] 
Kapoor L, et al. Giardiasis--clinical and diagnostic perspective. 2001. [128] 
Kapoor S, et al. Detecting protein losing enteropathy by Tc-99m dextran scintigraphy: A novel experience. 
2002. [129] 
Kirkpatrick BD, et al. Serum mannose-binding lectin deficiency is associated with cryptosporidiosis in young 
Haitian children. 2006. [130] 
Kirkpatrick BD, et al. Childhood cryptosporidiosis is associated with a persistent systemic inflammatory 
response. 2006. [131] 
Kirkpatrick BD, et al. Cryptosporidiosis stimulates an inflammatory intestinal response in malnourished Haitian 
children. 2002. [132] 
Kohli A, et al. Giardia duodenalis assemblage, clinical presentation and markers of intestinal inflammation in 
Brazilian children. 2008. [133] 
Kukuruzovic R, et al. Increased nitric oxide production in AD is associated with abnormal gut permeability, 
hypokalemia and malnutrition in tropical Australian aboriginal children. 2003. [43] 
Kukuruzovic R, et al. Milk formulas in acute gastroenteritis and malnutrition: a randomized trial. 2002. [134] 
Kukuruzovic R, et al. Small bowel intestinal permeability in Australian aboriginal children. 2002. [58] 
Laadhar L, et al. Determination of anti-transglutaminase antibodies in the diagnosis of celiac disease in 
children: results of a five year prospective study. 2004. [135] 
Leite CA, et al. Functional, microbiological and morphological intestinal findings among human 
immunodeficiency virus infected children. 2006. [136] 
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 Lima AA, et al. Effects of vitamin A supplementation on intestinal barrier function, growth, total parasitic, and 
specific Giardia spp infections in Brazilian children: a prospective randomized, double-blind, placebo-controlled 
trial. 2010. [137] 
Lima AA, et al. Intestinal barrier function and weight gain in malnourished children taking glutamine 
supplemented enteral formula. 2005. [138] 
Lima NL, et al. Wasting and intestinal barrier function in children taking alanyl-glutamine-supplemented enteral 
formula. 2007. [139] 
Long KZ, et al. The effect of vitamin A supplementation on the intestinal immune response in Mexican children 
is modified by pathogen infections and diarrhea. 2006. [140] 
López de Romaña D, et al. Longitudinal measurements of zinc absorption in Peruvian children consuming 
wheat products fortified with iron only or iron and 1 of 2 amounts of zinc. 2005. [141] 
Mahmud MA, et al. Sociodemographic, environmental and clinical risk factors for developing persistent diarrhea 
among infants in a rural community of Egypt. 2001. [142] 
Mahmud MA, et al. Increased fecal IgE among infants in a rural community of Egypt: an analysis of associated 
risk factors. 2001. [143] 
Manary ML, et al. Zinc homeostasis in Malawian children consuming a high-phytate, maize-based diet. 2002. 
[144] 
Mishra OP, et al. Endoscopic and histopathological evaluation of preschool children with chronic diarrhea. 
2001. [145] 
Mittal SK, et al. Tropical Sprue in North Indian Children. 2001. [146] 
Moya-Camarena SY, et al. Effects of asymptomatic Giardia intestinalis infection on carbohydrate absorption in 
well-nourished Mexican children. 2002. [147] 
Murphy JL, et al. Maldigestion and malabsorption of dietary lipid during severe childhood malnutrition. 2002. 
[148] 
Murphy JL, et al. Gastrointestinal handling and metabolic disposal of 13C-labelled tripalmitin during 
rehabilitation from childhood malnutrition. 2001. [149] 
Nichols B, et al. Contribution of villous atrophy to reduced intestinal maltase in infants with malnutrition. 2000. 
[53] 
Northrop-Clewes CA, et al. Anthelmintic treatment of rural Bangladeshi children: effect on host physiology, 
growth, and biochemical status. 2001. [150] 
Panter-Brick C, et al. Pathways leading to early growth faltering: An investigation into the importance of 
mucosal damage and immunostimulation in different socio-economic groups in Nepal. 2009. [151] 
Perin NM, et al. Intestinal absorption of D-xylose in children infected with the human immunodeficiency virus. 
2001. [152] 
Pires AL, et al. Digital morphometric and stereologic analysis of small intestinal mucosa in well-nourished and 
malnourished children with persistent diarrhea. 2003. [153] 
Poddar U, et al. Is tissue transglutaminase autoantibody the best for diagnosing celiac disease in children of 
developing countries? 2008. [154] 
Poddar U, et al. Celiac disease in India: Are they true cases of celiac disease? 2002. [155] 
Quadro L, et al. Retinol and retinol-binding protein: gut integrity and circulating immunoglobulins. 2000. [156] 
Rabbani GH, et al. Green banana and pectin improve small intestinal permeability and reduce fluid loss in 
Bangladeshi children with persistent diarrhea. 2004. [157] 
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 Rabbani GH, et al. Increased nitrite and nitrate concentrations in sera and urine of patients with cholera or 
shigellosis. 2001. [158] 
Ritchie BK, et al. 13C-sucrose breath test: novel use of a noninvasive biomarker of environmental gut health. 
2009. [159] 
Rollins NC, et al. Feeding mode, intestinal permeability, and neopterin excretion: A longitudinal study in infants 
of HIV-infected South African women. 2001. [160] 
Rollins NC, et al. Vitamin A supplementation of South African children with diarrhea: optimum timing for 
improving biochemical and clinical recovery and subsequent vitamin A status. 2000. [161] 
Samie A, et al. Cryptosporidium species: preliminary descriptions of the prevalence and genotype distribution 
among school children and hospital patients in the Venda region, Limpopo Province, South Africa. 2006. [162] 
Sarker SA, et al. Helicobacter pylori infection, iron absorption, and gastric acid secretion in Bangladeshi 
children. 2004. [163] 
Sheng XY, et al. Major variables of zinc homeostasis in Chinese toddlers. 2006. [164] 
Sherwani K, et al. Prevalence of iron deficiency anemia in chronic diarrhoea and celiac disease - A western UP 
experience. 2008. [165] 
Soliman SM, et al. Role of micronutrient mixture in acute and persistent diarrhea in infants and its impact on 
nutritional status. 2003. [166] 
Tassara O, et al. Gastrointestinal diseases in children infected with the human immunodeficiency virus. 2003. 
[167] 
Thurnham DI, et al. Innate immunity, gut integrity, and vitamin A in Gambian and Indian infants. 2000. [168] 
Trehan I, et al. A randomized, double-blind, placebo-controlled trial of rifaximin, a nonabsorbable antibiotic, in 
the treatment of tropical enteropathy. 2009. [13] 
Vieira MM, et al. Carotenoids, retinol, and intestinal barrier function in children from northeastern Brazil. 2008. 
[169] 
Williams EA, et al. A double-blind, placebo-controlled, glutamine-supplementation trial in growth-faltering 
Gambian infants. 2007. [170]  
Willumsen JF, et al. Subclinical mastitis as a risk factor for mother-infant HIV transmission. 2000. [171] 
Zhang Y, et al. Lactulose-mannitol intestinal permeability test in children with diarrhea caused by rotavirus and 























*One of the studies attributed only to The Gambia in this map had two study locations: The Gambia and India.
Figure 7. Geographic mapping of study sites 
Number of studies by country included in the systematic review. 
 Aggregated characteristics of the included studies are presented in Table 10. Details of 
the data from each article are reported in the Evidence Table of all studies included in the 
review (Appendix 7). Data are also presented in individual Evidence Tables based on category 
of biomarker (Evidence Tables 1-8). It is important to note that we only include data from articles 
that pertain to our review question. No identified study was explicitly designed to assess the 
accuracy of the diagnostic tests or biomarkers that they employed among children in 
developing-country settings. While this does not detract from their intrinsic value, it does pose 
an additional challenge to our goal of evaluating diagnostics for EED. For example, we did not 
find data pertaining specifically to standard measures of diagnostic test evaluation, such as 
positive or negative predictive values, or receiver operating characteristic curves. We assessed 
the use of the biomarkers as they were employed and extracted data relevant to the markers 
themselves, even if these data were not the primary focus of the studies.  
Table 10. Overview of studies. 
Characteristics of studies are provided and demonstrate broad-based nature of current and 
recent data.  
Study sites by WHO regions, countries: Number of studies 
WPRO: China (1), Australia (5) 
AMRO: Brazil (16), Haiti (3), Mexico (2), Peru (2),  
  Venezuela (1), Chile (1), Bolivia (1), Jamaica (2) 
AFRO: Zambia (1), Malawi (3), The Gambia (6),  
  South Africa (5), Uganda (2) 
EMRO: Saudi Arabia (1), Pakistan (2), Egypt (3), Tunisia (1) 
SEARO: India (10), Bangladesh (7), Nepal (2) 


















 Study durations: Time period for subject enrollment 
Median: 502 days 
Range: 28 days – 17 years  
Not specified: 27 studies 
Publication Lag: Time from study enrollment to publication 
Median: 4 years  
Range: 1 year – 15 years  
Not specified: 37 studies 




Urban slum1: 7 
Study designs: Number of studies 
Case-controls: 25 
Longitudinal cohort: 14  
Randomized controlled trial: 16  
Cross-sectional: 12  
Case-series: 10 
 
Sample size of subjects of interest: Number of subjects in all studies combined 
Total: 7730    
Interquartile Range: 104 
Median: 75    
Range: 3-318 
Age range of subjects investigated in all studies combined  
Range: birth-88 years  
Subjects of interest to this review under five years of age: Number of subjects all studies combined 
Total: 54192     
Interquartile range: 119 
Median: 71     
Range: 3-306 
Presenting conditions of study subjects of interest at the time of recruitment: Number of studies3 
Acute Diarrhea: 27 
Persistent Diarrhea: 30 
Infection with specific enteric pathogens: 28 
   Cryptosporidium (8) 
   Giardia (11) 
   Helminths (4) 
   Helicobacter pylori (3) 
   Other (13) 
Malnutrition: 45 
Infected with HIV or Tuberculosis: 9 
Healthy / asymptomatic: 40 
Other: 18 
                                                     
1 This comprises any study noted as being conducted in a slum, shantytown, or urban squatter settlement. 
2 Excluding 22 studies that do not specify subjects <4 and 5 years. 
3 Number >77 because some studies included more than one condition or test. 
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Lactulose:rhamnose ratio (L:R): 5  
α-1-acid glycoprotein: 4 
CRP: 5 
Red blood cell indices (e.g., Mean 
corpuscular volume): 4 
WBC: 4 
Total protein: 3 
D-xylose: 2  
Transferrin (saturation): 2  
α-1-antichymotrypsin: 2 
Cytokines: 1 
Immune function assays: 1 
Mannose-binding lectin: 1  
Nitric oxide: 1 
Oxidative stress markers, DNA 
   damage to lymphocytes, liver  
   enzymes, thyroid hormones: 1 




13C lipid breath test: 1 
13C sucrose breath test: 1  
Hydrogen breath test  
  Lactose: 2 
  Lactulose: 1 
  Xylose: 1 
 
Urine (32) 
Lactulose:mannitol (L:M): 255  
Radiolabeled zinc or lipid    
  challenge: 3 
Neopterin: 2 
Nitric oxide: 2 
Sucrose:lactulose ratio: 26 
D-xylose: 1 
Lactose:lactulose ratio: 17 
Lactulose:rhamnose (L:R): 1  
Sucralose:lactulose ratio: 18 
  
Stool (24) 
Lactoferrin: 9  
Leukocytes: 4 
Cytokines: 5 
Fecal fat: 3  
Radiolabeled zinc or lipid   
  challenge: 4 
Reducing substances: 4  
Occult blood/RBCs by    






Small intestinal aspirates (2) 
Concentrations of  
  immunoglobulins (Ig) IgA, IgG,  
  and IgM: 1 
Microbial concentrations: 1 
 
 




Small intestinal tissue (18) 
Histopathology: 17 
Disaccharidases: 2 
Protein and inflammatory  
  markers: 2 
Messenger RNA abundances: 1 
 
 
Site not specified (2) 
D-xylose: 2 
For studies that included small intestinal biopsy, characteristics specific to biopsy results: 
 
Total subjects of interest: 996 
 
Subjects of interest under five years of age: 8 studies specified   
  (n=311), 10 did not specify 
 
Site of small intestinal biopsy: Number of studies 
- Duodenum: 11  
- Jejunum or ileum: 4 
- Not specified: 3 
 
Esophagus or stomach also biopsied: 1 
Large intestine or rectum also biopsied: 2 
                                                     
4 Number >77 because some studies included more than one condition or test. 
5 18 of the 25 studies include fractional excretion of the individual components. 
6 Includes fractional excretion of the individual components. 
7 Includes fractional excretion of the individual components; there was also one study that measured lactose 
excretion individually without relationship to another sugar. 
8 Includes fractional excretion of the individual components. 
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Comparison of biomarkers to histopathology: Number of studies 
Yes: 3 studies compared extra-intestinal tissue markers to 
histopathology: D-xylose (2)9; Fecal fat (1); L:M (1)10 
 
Yes: 3 studies compared endoscopic visualization or intestinal 
tissue markers to histopathology: Intestinal maltase activity and 
various intestinal mRNA abundances (1), endoscopic gross 
visualization (1), scanning electron microscopy (compared to 
light microscopy) (1) 
 
No: 71 studies 
Comparison of extra-intestinal tissue biomarkers to other extra-intestinal tissue biomarkers: Number of 
studies 
Yes: 12 studies11 comparing:  
L:M vs. albumin (1), Immunoglobulins (2), Alpha-1-acid 
glycoprotein AGP (1), Endotoxin and IgG endotoxin core 
antibody (1) Fecal neopterin (1); Lactose and Lactose:lactulose 
(1) 
 
Serum L:R vs. urinary L:R (1), sucrose breath test (1), urinary 
nitric oxide (1), serum lactose (1), reducing substances (1), red 
cell indices (1) 
Fecal lactoferrin vs. TNF-α receptor I (1), Urinary 
lactose:creatinine vs. hemoglobin (1); Urinary nitrites vs. stool 
reducing substances (1); Serum nitrites vs. WBC (1) 
 
No: 65 studies 
                                                     
9 One study compared D-xylose as well as fecal fat.  
10 This study compared the lactulose:mannitol ratio (L:M) to morphometric analysis of biopsy tissue. 
11 Number of comparisons listed is >12 because some studies included more than one comparison. 
 
We calculated that in the 77 papers analyzed, a total of 5,410 children under five years 
of age were studied for any biomarker plausibly related to EED, and an additional 2,311 children 
were studied, among whom the number of subjects aged under five years could not be 
determined (Table 10). More than 50 different biomarkers were studied. These biomarkers were 
obtained by study of urine, stool, blood, breath, and intestinal tissue. Eighteen studies examined 
the histopathology of biopsied intestinal tissue, but only three studies compared intestinal 
histopathology to non-intestinal tissue biomarkers (D-xylose; fecal fat; urinary L:M [111, 136, 
155]). One additional study compared results of intestinal tissue markers (maltase activity and 
intestinal mRNA abundances for various markers) to histopathology [53]. Notably, few small 
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 bowel biopsies (the “gold standard” diagnostic) among children under five years of age in 
developing-country settings are included in this cohort of studies from the past eleven years. 
Indeed, small bowel biopsies from only 311 children under five years of age in eight studies 
were reported, and an additional 685 children in 10 other studies had small bowel biopsies but 
the number of those who were under five years of age could not be determined.  
We were also interested in the lag time between study enrollment and publication, and 
examined a subset of the first 24 articles relevant to the systematic review. Table 11 provides 
intervals between enrollment, study start and close, study duration, and year of publication for a 
subset of the first 24 articles that we reviewed. There were, in general, long delays in cohort 
enrollment and dissemination of primary data (up to 19 years, and often over a decade).  
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Table 11. Study timing analysis. 
Dates of publication, enrollment, and performance of a subset of publications. Seven of 24 
studies did not specify study time interval. 
Publication 
Year Study enrollment years Range of study intervals 
2006 
Aug 1994-May 1995 
1991-2002 
30 days – date not specified 
1993-2002 
Not specified 
9 months – date not specified 




Sept 2001-October 2004 
2001-2004 July 2003-November 2004 
5 years – date not specified 
2008 
June 2003-February 2004 
1989-2004 
June 2003-April 2004 
Jan 2000-Dec 2002 
Not specified 
Aug 1989-Apr 1993 (current study 2004) 
July 2000-Aug 2001 
2009 
3 days- date not specified 
1998-2007 
Date not specified 









4.3 Classification of Biomarkers and Diagnostic 
Tests  
The “job description” of the small bowel can be reduced to a circumscribed set of tasks: 
break down specific nutrients using enzymes in the intestinal lining or by micellization of 
lipophilic substances; extract nutrients from food; exclude the food components that have no 
nutritive value and propel them distally for elimination; retain (i.e., not leak into the gut) 
molecules used (and often synthesized) by the host; and resist microbial breach of the barrier. 
Hence, the intestinal mucosa serves as a specialized transporting organ as well as a physical, 
physiologic, and antimicrobial interface between the host and the environment which in this 
case consists of ingested food and water, but also other potentially highly contaminated 
materials (e.g., soil) [173], given the oral-motor activities of infants and toddlers. The cells and 
submucosa that line the small bowel are, therefore, critical for assimilation of nutrients, 
maintenance of structural integrity, and protection against microbial assault. In injury, 
substances are absorbed by barrier breach rather than by physiologic transport or diffusion.  
We strove to take an unbiased and uniform approach to classifying the EED markers. 
Our classification system was blinded to the assertions of study authors regarding marker 
category; however we did find that investigators’ categorizations were largely consistent with 
ours. Our classification system was based on the primary function/dysfunction that the test is 
likely to measure or the underlying pathophysiology and pathogenesis that the test may likely 
reflect. For example, the amount of D-xylose that is absorbed after an oral challenge is believed 
to reflect gut absorptive capacity, and D-xylose uptake from the challenge, measured either in 
the blood or urine, is therefore classified as a test of gut absorption. We also aimed to 
unambiguously place a marker in one group based on best fit when possible, though we 
recognize that markers might detect derangements of multiple functions. For example, the 
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 presence of lactose in the blood or urine likely indicates a loss of lactase enzyme in the 
intestinal brush border, and thus can be a marker of abnormal digestion or nonspecific intestinal 
injury. However, for lactose to traverse the mucosa and gain access to the systemic circulation, 
a porosity defect is needed. Hence, we chose to place this marker in the permeability category.  
Finally, we recognize that many tests reflect nonspecific injury and processes, which 
cannot be so easily binned into mechanistic or pathophysiologic categories. For example, while 
measures of surface area on a biopsy provide a general impression of absorptive capacity, we 
categorize histopathology as a measure of nonspecific injury, as the visualization of tissue 
portrays a general picture of derangements in architecture without specifying function.  
With these factors in mind, we formulated eight test categories, classified in Table 12, 
and constructed evidence tables based on these classifications. 
Table 12. Classification framework for biomarkers of intestinal function/dysfunction and 
inflammation. 
Evidence 
Table Type of Functional Measure 
1 Absorption 
2 Porosity/permeability (with or without assessment of absorption) 
3 Digestion 
4 Intestinal inflammation and/or intestinal immune activation 
5 Systemic inflammation and/or systemic immune activation 
6 Microbial drivers 
7 Nonspecific intestinal injury 
8 Non-small intestine organ function 
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